{
    "clinical_study": {
        "@rank": "84103", 
        "arm_group": {
            "arm_group_label": "Aortic Repair", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The HAART 200 \"Aortic Annuloplasty during Bicuspid Aortic Valve Reconstruction\" Trial is a\n      prospective, non-randomized, multi-center trial to evaluate the safety and effectiveness of\n      the HAART 200 bicuspid annuloplasty ring when used to surgically stabilize the aortic valve\n      annulus in patients undergoing repair of bicuspid aortic valves (BAV) for predominant aortic\n      insufficiency (AI)."
        }, 
        "brief_title": "HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Insufficiency", 
        "condition_browse": {
            "mesh_term": [
                "Aortic Valve Insufficiency", 
                "Aortic Valve Stenosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. The subject is 18 years of age or older\n\n          2. The subject has bi-leaflet aortic valve morphology\n\n          3. The subject has documented aortic valve disease which may or may not include:\n\n               -  Aortic valve insufficiency\n\n               -  Ascending aortic or aortic root pathology\n\n               -  Other pathology of the ascending aorta that requires elective aortic replacement\n\n               -  Associated stable one or two vessel coronary disease requiring concomitant\n                  coronary bypass\n\n               -  Patients with recurrent severe AI (Grade 3 or 4) after prior bicuspid repair who\n                  are undergoing re-repair because of annular re-dilatation\n\n               -  All bicuspid annular and leaflet configurations will be included\n\n          4. The subject needs:\n\n               -  correction of BAV annular dilatation in patients with chronic AI and dilated\n                  annulus\n\n               -  restoration of a circular annular shape in patients with bicuspid valve and\n                  expansion of sinus to sinus dimensions\n\n               -  stabilization of annular geometry long-term in rare bicuspid valve patients with\n                  severe AI and minimal annular dilatation\n\n          5. The is willing to comply with specified follow-up evaluations, including\n             transesophageal echocardiography (TEE)    if there are inadequate images by\n             transthoracic echocardiography (TTE) to assess the aortic valve\n\n          6. The subject has reviewed and signed the written informed consent form\n\n          7. The subject agrees to return for all follow-up evaluations for the duration of the\n             study (i.e. geographically stable)\n\n        Exclusion Criteria:\n\n          1. All patients will be excluded who require emergency surgery for any reason.\n\n          2. All the patients who have had a prior heart valve replacement\n\n          3. The subject's aortic valve morphology is not bicuspid.\n\n          4. The subject has active endocarditis\n\n          5. The subject has mixed stenosis and regurgitation of the aortic valve with predominant\n             stenosis\n\n          6. Heavily calcified BAV valves, calcified aortic roots, or \"porcelain aortas\"\n\n          7. Leukopenia with a White Blood Cell (WBC) of less than 3000\n\n          8. Acute anemia with a Hgb less than 9mg%\n\n          9. Platelet count less than 100,000 cells/mm3\n\n         10. History of a defined bleeding diathesis or coagulopathy or the subject refuses blood\n             transfusions\n\n         11. Active infection requiring antibiotic therapy (if temporary illness, subjects may\n             enroll 2-4 weeks after discontinuation of antibiotics)\n\n         12. Subjects in whom transesophageal echocardiography (TEE) is contraindicated\n\n         13. Low Ejection Fraction (EF) < 35%\n\n         14. Life expectancy < 1 year, or severe comorbidities, such as dialysis or severe Chronic\n             Obstructive Pulmonary Disease (COPD)\n\n         15. The subject is or will be participating in a concomitant research study of an\n             investigational product or has participated in such a study within the 30 days prior\n             to screening\n\n         16. The subject is a minor, an illicit drug user, alcohol abuser, prisoner,\n             institutionalized, or is unable to give informed consent\n\n         17. The subject is pregnant or lactating\n\n         18. Recent (within 6 months) cerebrovascular accident (CVA) or a transient ischemic\n             attack (TIA)\n\n         19. Myocardial Infarction (MI) within one month of trial inclusion\n\n         20. The subject has a known intolerance to titanium or polyester\n\n         21. The subject has documented unstable or > 2 vessel coronary disease\n\n         22. The subject requires additional valve replacement or valve repair"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02071849", 
            "org_study_id": "TP-01-025"
        }, 
        "intervention": {
            "arm_group_label": "Aortic Repair", 
            "description": "Surgical repair of bicuspid aortic valves.", 
            "intervention_name": "Bicuspid Aortic Valve Repair", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Aortic Insufficiency", 
            "Aortic Regurgitation"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": [
            {
                "contact": {
                    "email": "mazzitelli@dhm.mhn.de", 
                    "last_name": "Dominico Dominico Mazzitelli, MD", 
                    "phone": "089 1218 4474"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "state": "Bavaria", 
                        "zip": "80636"
                    }, 
                    "name": "M\u00fcnchen Heart Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "yeong-hoon.choi@uk-koeln.de", 
                    "last_name": "Yeong Choi, M.D.", 
                    "phone": "+49 221 478 32507"
                }, 
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany", 
                        "state": "North Rhine-Westphalia", 
                        "zip": "50937"
                    }, 
                    "name": "Uniklinik K\u00f6ln"
                }, 
                "investigator": {
                    "last_name": "Yeong-Hoon Choi, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "detter@uke.de", 
                    "last_name": "Christian Detter, MD", 
                    "phone": "+49 40 7410 58949"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany", 
                        "zip": "20246"
                    }, 
                    "name": "Klinik und Poliklinik f\u00fcr Herz- und Gef\u00e4\u00dfchirurgie"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "steffen.pfeiffer@klinikum-nuernberg.de", 
                    "last_name": "Steffen Pfeiffer, MD", 
                    "phone": "+49 911 398 5442"
                }, 
                "facility": {
                    "address": {
                        "city": "N\u00fcrnberg", 
                        "country": "Germany", 
                        "zip": "90471"
                    }, 
                    "name": "Klinikum N\u00fcrnberg S\u00fcd"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "official_title": "HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction", 
        "overall_contact": {
            "email": "debby.powers@biostable-s-e.com", 
            "last_name": "Debby Powers, MSN", 
            "phone": "512-739-8665"
        }, 
        "overall_official": {
            "affiliation": "M\u00fcnchen Heart Center", 
            "last_name": "Dominico Mazzitelli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Survival described as, survival free from all cause death at the 6 month postoperative time point.", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02071849"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "The change in Aortic Insufficiency (AI), as measured by transthoracic echocardiography from baseline through the 6 month postoperative echo.", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Biostable Science & Engineering", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biostable Science & Engineering", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}